inPROBE Overview
inPROBE® diagnostic technology
- First photonic real-time immunoassay system, utilizing molecular biology, chemistry, and biomedical engineering
- Real-time detection of HER2 biomarker and potentionally also other proteins, antibodies and peptides, including other cancer biomarkers
- Potential point-of-care diagnostic aid to support and reduce the time to diagnosis
- Novel analyzer with photonic sensor probe consisting of 4 microprobes for biomarker detection in tissue and liquid samples
- Each microprobe tip covered with monoclonal antibodies (mAbs) for HER2 or other chosen target detection
How inPPROBE works in HER2 biomarker detection in breast cancer
inPPROBE is a new diagnostic technology combining photonics with molecular biology to detect HER2 expression in breast cancer. This point-of-care solution offers the potential to complement immunohistochemistry (IHC) and in situ hybridization (ISH) assays, addressing HER2 heterogeneity to improve access to targeted therapies such as trastuzumab and novel ADCs.
